Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events.
Schouten
Olaf
O
van Domburg
Ron T
RT
Bax
Jeroen J
JJ
de Jaegere
Peter J
PJ
Dunkelgrun
Martin
M
Feringa
Harm H H
HH
Hoeks
Sanne E
SE
Poldermans
Don
D
D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D003324:Coronary Artery Disease / Q000628:therapy; D003643:Death; D016503:Drug Delivery Systems; D006331:Heart Diseases / Q000209:etiology / Q000401:mortality*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012042:Registries; D012189:Retrospective Studies; D015607:Stents; D013514:Surgical Procedures, Operative / Q000009:adverse effects*; D013997:Time Factors
D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors